A board-level executive with over 35 years of experience in the pharmaceutical industry, from large multinationals to emerging biotech. Holding a PhD from The University of Edinburgh, he has a strong record of blending scientific training with commercial leadership, notably during his 18 years as CEO of Quotient Sciences.
He is passionate about creating high-performing teams to translate high-impact science and technology into tangible value for patients, employees, and shareholders. His current focus is on providing strategic guidance and leadership in non-executive and advisory capacities.
After a successful 18-year tenure as CEO, he consciously decided to retire from full-time executive life to contribute his expertise as a chairman and advisor.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.